ID EYA3_MOUSE Reviewed; 510 AA. AC P97480; G5E8I5; P97768; DT 15-JUL-1998, integrated into UniProtKB/Swiss-Prot. DT 03-OCT-2012, sequence version 2. DT 02-SEP-2026, entry version 184. DE RecName: Full=Protein phosphatase EYA3 {ECO:0000305}; DE EC=3.1.3.48 {ECO:0000269|PubMed:14628042, ECO:0000269|PubMed:14628052, ECO:0000269|PubMed:14628053}; DE AltName: Full=Eyes absent homolog 3; GN Name=Eya3; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Embryo; RX PubMed=9049631; DOI=10.1101/gr.7.2.128; RA Zimmerman J.E., Bui Q.T., Steingrimsson E., Nagle D.L., Fu W., Genin A., RA Spinner N.B., Copeland N.G., Jenkins N.A., Bucan M., Bonini N.M.; RT "Cloning and characterization of two vertebrate homologs of the Drosophila RT eyes absent gene."; RL Genome Res. 7:128-141(1997). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RC TISSUE=Embryo; RX PubMed=9006082; DOI=10.1242/dev.124.1.219; RA Xu P.-X., Woo I., Her H., Beier D.R., Maas R.L.; RT "Mouse Eya homologues of the Drosophila eyes absent gene require Pax6 for RT expression in lens and nasal placode."; RL Development 124:219-231(1997). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] OF 350-468. RC TISSUE=Embryo; RX PubMed=9887327; DOI=10.1093/hmg/8.1.11; RA Borsani G., DeGrandi A., Ballabio A., Bulfone A., Bernard L., Banfi S., RA Gattuso C., Mariani M., Dixon M., Donnai D., Metcalfe K., Winter R., RA Robertson M., Axton R., Brown A., van Heyningen V., Hanson I.; RT "EYA4, a novel vertebrate gene related to Drosophila eyes absent."; RL Hum. Mol. Genet. 8:11-23(1999). RN [6] RP FUNCTION, INTERACTION WITH SIX2; SIX4 AND SIX5, AND SUBCELLULAR LOCATION. RX PubMed=10490620; DOI=10.1128/mcb.19.10.6815; RA Ohto H., Kamada S., Tago K., Tominaga S., Ozaki H., Sato S., Kawakami K.; RT "Cooperation of six and eya in activation of their target genes through RT nuclear translocation of Eya."; RL Mol. Cell. Biol. 19:6815-6824(1999). RN [7] RP INTERACTION WITH SIX1; SIX2; SIX4 AND SIX5. RX PubMed=12215533; DOI=10.1128/mcb.22.19.6759-6766.2002; RA Ikeda K., Watanabe Y., Ohto H., Kawakami K.; RT "Molecular interaction and synergistic activation of a promoter by Six, RT Eya, and Dach proteins mediated through CREB binding protein."; RL Mol. Cell. Biol. 22:6759-6766(2002). RN [8] RP CATALYTIC ACTIVITY, INTERACTION WITH DACH1 AND SIX1, AND MUTAGENESIS OF RP ASP-246. RX PubMed=14628042; DOI=10.1038/nature02083; RA Li X., Oghi K.A., Zhang J., Krones A., Bush K.T., Glass C.K., Nigam S.K., RA Aggarwal A.K., Maas R., Rose D.W., Rosenfeld M.G.; RT "Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional RT effects in mammalian organogenesis."; RL Nature 426:247-254(2003). RN [9] RP ERRATUM OF PUBMED:14628042. RA Li X., Oghi K.A., Zhang J., Krones A., Bush K.T., Glass C.K., Nigam S.K., RA Aggarwal A.K., Maas R., Rose D.W., Rosenfeld M.G.; RL Nature 427:265-265(2004). RN [10] RP CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-246; RP ASP-248; THR-250; THR-419; GLY-473; ASP-474 AND GLU-478. RX PubMed=14628052; DOI=10.1038/nature02093; RA Rayapureddi J.P., Kattamuri C., Steinmetz B.D., Frankfort B.J., RA Ostrin E.J., Mardon G., Hegde R.S.; RT "Eyes absent represents a class of protein tyrosine phosphatases."; RL Nature 426:295-298(2003). RN [11] RP CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-246; THR-420; LYS-449; ASP-474 RP AND GLU-478. RX PubMed=14628053; DOI=10.1038/nature02097; RA Tootle T.L., Silver S.J., Davies E.L., Newman V., Latek R.R., Mills I.A., RA Selengut J.D., Parlikar B.E., Rebay I.; RT "The transcription factor Eyes absent is a protein tyrosine phosphatase."; RL Nature 426:299-302(2003). RN [12] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=17242355; DOI=10.1073/pnas.0609836104; RA Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; RT "Large-scale phosphorylation analysis of mouse liver."; RL Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). RN [13] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Lung, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Tyrosine phosphatase that specifically dephosphorylates 'Tyr- CC 142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation of histone CC H2AX plays a central role in DNA repair and acts as a mark that CC distinguishes between apoptotic and repair responses to genotoxic CC stress. Promotes efficient DNA repair by dephosphorylating H2AX, CC promoting the recruitment of DNA repair complexes containing MDC1 (By CC similarity). Its function as histone phosphatase probably explains its CC role in transcription regulation during organogenesis. The phosphatase CC activity has been shown in vitro. Coactivates SIX1. Seems to coactivate CC SIX2, SIX4 and SIX5. The repression of precursor cell proliferation in CC myoblasts by SIX1 is switched to activation through recruitment of EYA3 CC to the SIX1-DACH1 complex and seems to be dependent on EYA3 phosphatase CC activity. May be involved in development of the eye. May play a role in CC mediating the induction and differentiation of cranial placodes. CC {ECO:0000250|UniProtKB:Q99504, ECO:0000269|PubMed:10490620}. CC -!- CATALYTIC ACTIVITY: CC Reaction=O-phospho-L-tyrosyl-[protein] + H2O = L-tyrosyl-[protein] + CC phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA- CC COMP:20101, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858, CC ChEBI:CHEBI:61978; EC=3.1.3.48; CC Evidence={ECO:0000269|PubMed:14628042, ECO:0000269|PubMed:14628052, CC ECO:0000269|PubMed:14628053}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000250|UniProtKB:O00167}; CC Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250|UniProtKB:O00167}; CC -!- SUBUNIT: Interacts with SIX1 and DACH1, and probably SIX2, SIX4 and CC SIX5. {ECO:0000269|PubMed:10490620, ECO:0000269|PubMed:12215533, CC ECO:0000269|PubMed:14628042}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10490620}. Nucleus CC {ECO:0000269|PubMed:10490620, ECO:0000269|PubMed:14628052}. CC Note=Localizes at sites of DNA damage at double-strand breaks (DSBs). CC {ECO:0000250|UniProtKB:Q99504}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P97480-1; Sequence=Displayed; CC Name=2; CC IsoId=P97480-2; Sequence=VSP_001494; CC -!- TISSUE SPECIFICITY: Expressed in branchial arches, CNS and developing CC eye. CC -!- PTM: Ser-203 phosphorylation is required for localization at sites of CC DNA damage and directing interaction with H2AX. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the HAD-like hydrolase superfamily. EYA family. CC {ECO:0000305}. CC -!- CAUTION: According to PubMed:14628042 also shows serine/threonine CC protein phosphatase activity. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U81604; AAB42068.1; -; mRNA. DR EMBL; U61112; AAB48019.1; -; mRNA. DR EMBL; AL627130; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH466552; EDL30095.1; -; Genomic_DNA. DR EMBL; AJ007996; CAA07819.1; -; mRNA. DR CCDS; CCDS18730.1; -. [P97480-1] DR CCDS; CCDS18731.1; -. [P97480-2] DR RefSeq; NP_034296.2; NM_010166.4. [P97480-1] DR RefSeq; NP_997596.1; NM_211357.3. [P97480-2] DR AlphaFoldDB; P97480; -. DR SMR; P97480; -. DR BioGRID; 199561; 4. DR CORUM; P97480; -. DR FunCoup; P97480; 2945. DR IntAct; P97480; 4. DR MINT; P97480; -. DR STRING; 10090.ENSMUSP00000080425; -. DR BindingDB; P97480; -. DR ChEMBL; CHEMBL4296244; -. DR DrugCentral; P97480; -. DR iPTMnet; P97480; -. DR PhosphoSitePlus; P97480; -. DR PaxDb; 10090-ENSMUSP00000080425; -. DR PeptideAtlas; P97480; -. DR ProteomicsDB; 275707; -. [P97480-1] DR ProteomicsDB; 275708; -. [P97480-2] DR Pumba; P97480; -. DR Antibodypedia; 16480; 164 antibodies from 28 providers. DR DNASU; 14050; -. DR Ensembl; ENSMUST00000020197.14; ENSMUSP00000020197.8; ENSMUSG00000028886.16. [P97480-2] DR Ensembl; ENSMUST00000079157.11; ENSMUSP00000078157.5; ENSMUSG00000028886.16. [P97480-1] DR Ensembl; ENSMUST00000180250.8; ENSMUSP00000136812.2; ENSMUSG00000028886.16. [P97480-2] DR GeneID; 14050; -. DR KEGG; mmu:14050; -. DR UCSC; uc008vbo.2; mouse. [P97480-1] DR UCSC; uc008vbq.2; mouse. [P97480-2] DR AGR; MGI:109339; -. DR CTD; 2140; -. DR MGI; MGI:109339; Eya3. DR VEuPathDB; HostDB:ENSMUSG00000028886; -. DR eggNOG; KOG3107; Eukaryota. DR GeneTree; ENSGT00950000182978; -. DR HOGENOM; CLU_021184_2_0_1; -. DR InParanoid; P97480; -. DR OrthoDB; 167668at2759; -. DR Reactome; R-MMU-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks. DR SABIO-RK; P97480; -. DR BioGRID-ORCS; 14050; 2 hits in 116 CRISPR screens. DR PRO; PR:P97480; -. DR Proteomes; UP000000589; Chromosome 4. DR RNAct; P97480; protein. DR Bgee; ENSMUSG00000028886; Expressed in undifferentiated genital tubercle and 267 other cell types or tissues. DR ExpressionAtlas; P97480; baseline and differential. DR GO; GO:0005813; C:centrosome; ISO:GO_Central. DR GO; GO:0005737; C:cytoplasm; EXP:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; ISO:GO_Central. DR GO; GO:0005634; C:nucleus; IDA:MGI. DR GO; GO:0005667; C:transcription regulator complex; IPI:MGI. DR GO; GO:0003682; F:chromatin binding; IGI:MGI. DR GO; GO:0140793; F:histone H2AXY142 phosphatase activity; ISS:UniProtKB. DR GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:MGI. DR GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IDA:MGI. DR GO; GO:0030154; P:cell differentiation; IBA:GO_Central. DR GO; GO:0006302; P:double-strand break repair; ISS:UniProtKB. DR GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IBA:GO_Central. DR GO; GO:0045739; P:positive regulation of DNA repair; ISS:UniProtKB. DR GO; GO:0006470; P:protein dephosphorylation; IDA:MGI. DR GO; GO:0010212; P:response to ionizing radiation; ISS:UniProtKB. DR CDD; cd02601; HAD_Eya; 1. DR FunFam; 3.40.50.12350:FF:000002; Eyes absent homolog; 1. DR Gene3D; 3.40.50.12350; -; 1. DR InterPro; IPR028472; EYA. DR InterPro; IPR006545; EYA_dom. DR InterPro; IPR042577; EYA_dom_metazoan. DR InterPro; IPR038102; EYA_dom_sf. DR NCBIfam; TIGR01658; EYA-cons_domain; 1. DR PANTHER; PTHR10190; EYES ABSENT; 1. DR PANTHER; PTHR10190:SF5; EYES ABSENT HOMOLOG 3; 1. DR Pfam; PF00702; Hydrolase; 1. DR SFLD; SFLDG01129; C1.5:_HAD__Beta-PGM__Phosphata; 1. DR SFLD; SFLDS00003; Haloacid_Dehalogenase; 1. PE 1: Evidence at protein level; KW Activator; Alternative splicing; Chromatin regulator; Cytoplasm; KW Developmental protein; DNA damage; DNA repair; Hydrolase; Magnesium; KW Metal-binding; Nucleus; Phosphoprotein; Protein phosphatase; KW Reference proteome; Transcription; Transcription regulation. FT CHAIN 1..510 FT /note="Protein phosphatase EYA3" FT /id="PRO_0000218649" FT REGION 1..32 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 175..233 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 7..16 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 192..203 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 246 FT /note="Nucleophile" FT /evidence="ECO:0000250|UniProtKB:O00167" FT ACT_SITE 248 FT /note="Proton donor" FT /evidence="ECO:0000250|UniProtKB:O00167" FT BINDING 246 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:O00167" FT BINDING 248 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:O00167" FT BINDING 474 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:O00167" FT MOD_RES 199 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q99504" FT MOD_RES 203 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q99504" FT MOD_RES 375 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q99504" FT MOD_RES 409 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q99504" FT VAR_SEQ 1..105 FT /note="MQEPREQTLSQVNNPDASDEKPETSSLASNLSMSEEIMTCTDYIPRSSNDYT FT SQMYSAKPYAHILSVPVSETTYPGQTQYQTLQQSQPYAVYPQATQTYGLPPFA -> MI FT IPHKCILQT (in isoform 2)" FT /evidence="ECO:0000303|PubMed:9006082" FT /id="VSP_001494" FT MUTAGEN 246 FT /note="D->A: Abolishes phosphatase activity and abolishes FT coactivation of the SIX1-DACH1 complex." FT /evidence="ECO:0000269|PubMed:14628042, FT ECO:0000269|PubMed:14628052, ECO:0000269|PubMed:14628053" FT MUTAGEN 246 FT /note="D->N: Abolishes phosphatase activity." FT /evidence="ECO:0000269|PubMed:14628042, FT ECO:0000269|PubMed:14628052, ECO:0000269|PubMed:14628053" FT MUTAGEN 248 FT /note="D->N: Abolishes phosphatase activity." FT /evidence="ECO:0000269|PubMed:14628052" FT MUTAGEN 250 FT /note="T->A: Abolishes phosphatase activity." FT /evidence="ECO:0000269|PubMed:14628052" FT MUTAGEN 419 FT /note="T->A: Diminishes phosphatase activity by 24-fold." FT /evidence="ECO:0000269|PubMed:14628052" FT MUTAGEN 420 FT /note="T->A: Diminishes phosphatase activity." FT /evidence="ECO:0000269|PubMed:14628053" FT MUTAGEN 449 FT /note="K->Q: Abolishes phosphatase activity." FT /evidence="ECO:0000269|PubMed:14628053" FT MUTAGEN 473 FT /note="G->A: Abolishes phosphatase activity." FT /evidence="ECO:0000269|PubMed:14628052" FT MUTAGEN 474 FT /note="D->N: Diminishes phosphatase activity by 70%." FT /evidence="ECO:0000269|PubMed:14628052, FT ECO:0000269|PubMed:14628053" FT MUTAGEN 478 FT /note="E->Q: Abolishes phosphatase activity." FT /evidence="ECO:0000269|PubMed:14628052, FT ECO:0000269|PubMed:14628053" FT CONFLICT 200 FT /note="P -> L (in Ref. 2; AAB48019)" FT /evidence="ECO:0000305" FT CONFLICT 272 FT /note="V -> A (in Ref. 1; AAB42068)" FT /evidence="ECO:0000305" SQ SEQUENCE 510 AA; 55973 MW; E82CC71DD1FD05F5 CRC64; MQEPREQTLS QVNNPDASDE KPETSSLASN LSMSEEIMTC TDYIPRSSND YTSQMYSAKP YAHILSVPVS ETTYPGQTQY QTLQQSQPYA VYPQATQTYG LPPFASSTNA SLIPTSSAIA NIPAAAVASI SNQDYPTYTI LGQNQYQACY PSSSFGVTGQ TNSDAETTTL AATTYQTEKP SAMVPAPATQ RLPSDSSASP PLSQTTPNKD ADDQARKNMT VKNRGKRKAD ASSSQDSELE RVFLWDLDET IIIFHSLLTG SYAQKYGKDP TVVIGSGLTM EEMIFEVADT HLFFNDLEEC DQVHVEDVAS DDNGQDLSNY SFSTDGFSGS GGSGSHGSSV GVQGGVDWMR KLAFRYRKVR EIYDKHKSNV GGLLSPQRKE ALQRLRAEIE VLTDSWLGTA LKSLLLIQSR KNCANVLITT TQLVPALAKV LLYGLGEIFP IENIYSATKI GKESCFERIV SRFGKKVTYV VIGDGRDEEI AAKQHNMPFW RITNHGDLVS LHQALELDFL //